Evidence map›Paper›PMID 31753920›Full record

ArticleThe Journal of biological chemistry2020

The canonical non-homologous end joining factor XLF promotes chromosomal deletion rearrangements in human cells.

Ragini Bhargava, Felicia Wednesday Lopezcolorado, L Jillianne Tsai, Jeremy M Stark

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study.International journal of environmental research and public health · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ragini BhargavaDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute of the City of Hope, Duarte, California 91010; Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope, Duarte, California 91010.
Felicia Wednesday LopezcoloradoDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute of the City of Hope, Duarte, California 91010.
L Jillianne TsaiDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute of the City of Hope, Duarte, California 91010; Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope, Duarte, California 91010.
Jeremy M StarkDepartment of Cancer Genetics and Epigenetics, Beckman Research Institute of the City of Hope, Duarte, California 91010; Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope, Duarte, California 91010. Electronic address: jstark@coh.org.
City of Hope · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
Regulation of Single Strand Annealing Repair of Mammalian Chromosomal BreaksR01CA197506 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI STARK, JEREMY MICHAEL · 2016 to 2020
$1.9M
NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA197506
6 · The paper itself

Abstract

Clastogen exposure can result in chromosomal rearrangements, including large deletions and inversions that are associated with cancer development. To examine such rearrangements in human cells, here we developed a reporter assay based on endogenous genes on chromosome 12. Using the RNA-guided nuclease Cas9, we induced two DNA double-strand breaks, one each in the

Indexed as

Chromosome DeletionDNA End-Joining Repair1-Acylglycerophosphocholine O-AcyltransferaseA549 CellsCD4 AntigensChromosome InversionDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA Repair EnzymesGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)HEK293 CellsHumansPromoter Regions, Genetic1-Acylglycerophosphocholine O-AcyltransferaseCD4 AntigensDNA-Binding ProteinsDNA Repair EnzymesGAPDH protein, humanGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)LPCAT3 protein, humanNHEJ1 protein, humanXRCC4 protein, humanATM kinasecanonical non-homologous end joiningchromosomal rearrangementCRISPR/CasDNA damageDNA damage responseDNA repairgenomic instabilityreporter gene assayXRCC4-like factor (XLF)

Identifiers

PMID31753920
PMCPMC6952595
OpenAlexW2989576725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.